ATAI Life Sciences NV (9VC) — Defensive Interval Ratio
ATAI Life Sciences NV (9VC) has a Defensive Interval Ratio of 1858 days as of September 2025. Defensive assets of €84.20 Million (cash €-, short-term investments €84.20 Million, receivables €-) cover 1858 days of daily cash needs of €45.33K/day. Check ATAI Life Sciences NV tangible equity quality to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ATAI Life Sciences NV Defensive Interval Ratio (2021–2024)
This chart shows how ATAI Life Sciences NV's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 1858 days, meaning defensive assets of €84.20 Million can fund 1858 days of operations without new revenue. Also explore ATAI Life Sciences NV equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for ATAI Life Sciences NV (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for ATAI Life Sciences NV from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 9VC stock market capitalisation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 656 days | €44.83 Million | €68.36K/day | €- | €44.83 Million | ▼ -1779 days |
| 2023 | 2435 days | €134.22 Million | €55.12K/day | €- | €134.22 Million | ▲ +922 days |
| 2022 | 1513 days | €82.50 Million | €54.51K/day | €- | €82.50 Million | ▲ +1513 days |
| 2021 | 0 days | €0.00 | €57.36K/day | €- | €0.00 | — |